应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CRMD CorMedix Inc.
交易中 12-23 13:22:36 EST
8.38
-0.19
-2.22%
最高
8.55
最低
8.17
成交量
31.70万
今开
8.55
昨收
8.57
日振幅
4.46%
总市值
5.08亿
流通市值
5.04亿
总股本
6,068万
成交额
265.04万
换手率
0.53%
流通股本
6,010万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Cormedix Inc.盘中异动 股价大涨5.17%
市场透视 · 12-19
Cormedix Inc.盘中异动 股价大涨5.17%
美国研究综述-亚马逊、万事达卡、特斯拉
路透中文 · 12-19
美国研究综述-亚马逊、万事达卡、特斯拉
Cormedix Inc.盘中异动 股价大跌5.03%报9.05美元
市场透视 · 12-12
Cormedix Inc.盘中异动 股价大跌5.03%报9.05美元
Cormedix Inc.盘中异动 早盘股价大跌5.04%
市场透视 · 12-03
Cormedix Inc.盘中异动 早盘股价大跌5.04%
Cormedix Inc.盘中异动 股价大跌5.03%报9.45美元
市场透视 · 11-27
Cormedix Inc.盘中异动 股价大跌5.03%报9.45美元
Cormedix Inc.盘中异动 急速上涨5.03%
市场透视 · 11-19
Cormedix Inc.盘中异动 急速上涨5.03%
Cormedix Inc.盘中异动 临近午盘急速下跌5.00%报10.45美元
市场透视 · 11-16
Cormedix Inc.盘中异动 临近午盘急速下跌5.00%报10.45美元
Cormedix Inc.盘中异动 大幅拉升5.09%
市场透视 · 11-12
Cormedix Inc.盘中异动 大幅拉升5.09%
Cormedix Inc.2024财年第三财季实现净利润-2.78百万美元,同比增加71.46%
市场透视 · 11-09
Cormedix Inc.2024财年第三财季实现净利润-2.78百万美元,同比增加71.46%
Cormedix Inc.盘中异动 股价大涨5.08%
市场透视 · 11-08
Cormedix Inc.盘中异动 股价大涨5.08%
Cormedix Inc.盘中异动 早盘股价大涨5.11%
市场透视 · 11-06
Cormedix Inc.盘中异动 早盘股价大涨5.11%
异动解读 | CorMedix Inc.股价大涨5.11% 分析师看好主打产品前景
异动解读 · 11-04
异动解读 | CorMedix Inc.股价大涨5.11% 分析师看好主打产品前景
Cormedix Inc.盘中异动 快速上涨5.11%
市场透视 · 11-04
Cormedix Inc.盘中异动 快速上涨5.11%
异动解读 | CorMedix 财报数据不佳导致股价大跌近26%
异动解读 · 10-30
异动解读 | CorMedix 财报数据不佳导致股价大跌近26%
CorMedix Inc 报告截至 1 月 1 日的季度业绩 - 收益摘要
Reuters · 10-30
CorMedix Inc 报告截至 1 月 1 日的季度业绩 - 收益摘要
Cormedix Inc.盘中异动 临近收盘快速跳水5.00%
市场透视 · 10-30
Cormedix Inc.盘中异动 临近收盘快速跳水5.00%
CorMedix Inc 预计每股亏损 10 美分 - 财报前瞻
Reuters · 10-28
CorMedix Inc 预计每股亏损 10 美分 - 财报前瞻
Cormedix Inc.盘中异动 急速拉升5.13%
市场透视 · 10-25
Cormedix Inc.盘中异动 急速拉升5.13%
Cormedix Inc.盘中异动 大幅下挫5.01%
市场透视 · 10-24
Cormedix Inc.盘中异动 大幅下挫5.01%
Cormedix Inc.盘中异动 下午盘股价大涨5.01%
市场透视 · 10-23
Cormedix Inc.盘中异动 下午盘股价大涨5.01%
加载更多
公司概况
公司名称:
CorMedix Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
CorMedix Inc.是于2006年7月28日在美国特拉华州注册成立。该公司是一家生物制药公司,专注于开发和商业化治疗产品,用于预防和治疗危及生命的疾病和状况。该公司的主要重点是主导产品DefenCath的商业化。该公司已在全球范围内授权开发和商业化DefenCath。DefenCath这个名称是美国食品药品监督管理局(FDA)批准的美国专有名称。
发行价格:
--
{"stockData":{"symbol":"CRMD","market":"US","secType":"STK","nameCN":"CorMedix Inc.","latestPrice":8.38,"timestamp":1734978141934,"preClose":8.57,"halted":0,"volume":317049,"delay":0,"floatShares":60098088,"shares":60677204,"eps":-0.797644,"marketStatus":"交易中","marketStatusCode":2,"change":-0.19,"latestTime":"12-23 13:22:36 EST","open":8.55,"high":8.55,"low":8.1677,"amount":2650430.4036629996,"amplitude":0.044609,"askPrice":8.39,"askSize":11,"bidPrice":8.38,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-0.797644,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734987600000},"adr":0,"listingDate":1273723200000,"adjPreClose":8.57,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":8.6,"preClose":8.57,"latestTime":"09:28 EST","volume":3810,"amount":33190.42257,"timestamp":1734964120084},"postHourTrading":{"tag":"盘后","latestPrice":8.75,"preClose":8.57,"latestTime":"19:08 EST","volume":347974,"amount":2982166.5445,"timestamp":1734739698158},"volumeRatio":0.417556,"impliedVol":0.481,"impliedVolPercentile":0.1116},"requestUrl":"/m/hq/s/CRMD","defaultTab":"news","newsList":[{"id":"2492174277","title":"Cormedix Inc.盘中异动 股价大涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492174277","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492174277?lang=zh_cn&edition=full","pubTime":"2024-12-19 22:31","pubTimestamp":1734618688,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日22时31分,Cormedix Inc.股票出现波动,股价快速上涨5.17%。截至发稿,该股报8.54美元/股,成交量4.1313万股,换手率0.07%,振幅2.59%。Cormedix Inc.股票所在的生物技术行业中,整体跌幅为2.72%。Cormedix Inc.公司简介:Cormedix Inc 是一家生物制药公司,专注于开发和商业化用于预防和治疗传染病和炎症性疾病的治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219223136ab849ea0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219223136ab849ea0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CRMD"],"gpt_icon":0},{"id":"2492468114","title":"美国研究综述-亚马逊、万事达卡、特斯拉","url":"https://stock-news.laohu8.com/highlight/detail?id=2492468114","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492468114?lang=zh_cn&edition=full","pubTime":"2024-12-19 14:58","pubTimestamp":1734591497,"startTime":"0","endTime":"0","summary":"美国研究综述-亚马逊、万事达卡、特斯拉路透12月19日 - 华尔街证券分析师周四调整了对亚马逊、万事达卡和特斯拉等多家美国上市公司的评级和目标价。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nL4T3NK0JV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASLE","EAT","TENB","LU0820561909.HKD","AIN","ZG","TGI","WOR","CRMD","TSYW.SI","FHN","WM","LU1989772923.USD","TPR","MNRO","HXL","TSLA","VRNS","LU0444971666.USD","LU0096362180.USD","PANW","NET","OKTA","DSP","FTNT","BROS","TKO","S","LU1674673691.USD","MA","FI","UPWK","LU1121112475.USD","ACHC","META","ANAB","USAW.SI","AMZN","V","LU2456880835.USD","LU0708994859.HKD","IE00BJJMRY28.SGD","LU0672654240.SGD","MNKD","GIS"],"gpt_icon":1},{"id":"2490380124","title":"Cormedix Inc.盘中异动 股价大跌5.03%报9.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490380124","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490380124?lang=zh_cn&edition=full","pubTime":"2024-12-12 23:08","pubTimestamp":1734016123,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日23时08分,Cormedix Inc.股票出现波动,股价急速跳水5.03%。截至发稿,该股报9.05美元/股,成交量9.4364万股,换手率0.16%,振幅4.51%。Cormedix Inc.股票所在的生物技术行业中,整体跌幅为0.55%。Cormedix Inc.公司简介:Cormedix Inc 是一家生物制药公司,专注于开发和商业化用于预防和治疗传染病和炎症性疾病的治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212230843ab72ba85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212230843ab72ba85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRMD","BK4007"],"gpt_icon":0},{"id":"2488947879","title":"Cormedix Inc.盘中异动 早盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488947879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488947879?lang=zh_cn&edition=full","pubTime":"2024-12-03 23:51","pubTimestamp":1733241072,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日23时51分,Cormedix Inc.股票出现波动,股价急速跳水5.04%。截至发稿,该股报9.40美元/股,成交量17.5857万股,换手率0.29%,振幅4.85%。Cormedix Inc.股票所在的生物技术行业中,整体跌幅为0.50%。Cormedix Inc.公司简介:Cormedix Inc 是一家生物制药公司,专注于开发和商业化用于预防和治疗传染病和炎症性疾病的治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203235113abf32153&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203235113abf32153&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CRMD"],"gpt_icon":0},{"id":"2486881100","title":"Cormedix Inc.盘中异动 股价大跌5.03%报9.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486881100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486881100?lang=zh_cn&edition=full","pubTime":"2024-11-27 01:24","pubTimestamp":1732641846,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日01时24分,Cormedix Inc.股票出现波动,股价快速下跌5.03%。截至发稿,该股报9.45美元/股,成交量64.0587万股,换手率1.06%,振幅6.03%。Cormedix Inc.股票所在的生物技术行业中,整体涨幅为0.10%。Cormedix Inc.公司简介:Cormedix Inc 是一家生物制药公司,专注于开发和商业化用于预防和治疗传染病和炎症性疾病的治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112701240698e44ba8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112701240698e44ba8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CRMD"],"gpt_icon":0},{"id":"2484609686","title":"Cormedix Inc.盘中异动 急速上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484609686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484609686?lang=zh_cn&edition=full","pubTime":"2024-11-19 01:32","pubTimestamp":1731951148,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日01时32分,Cormedix Inc.股票出现异动,股价急速拉升5.03%。截至发稿,该股报10.85美元/股,成交量50.4138万股,换手率0.83%,振幅5.18%。Cormedix Inc.股票所在的生物技术行业中,整体涨幅为0.04%。Cormedix Inc.公司简介:Cormedix Inc 是一家生物制药公司,专注于开发和商业化用于预防和治疗传染病和炎症性疾病的治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119013228abccfa0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119013228abccfa0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRMD","BK4007"],"gpt_icon":0},{"id":"2483629302","title":"Cormedix Inc.盘中异动 临近午盘急速下跌5.00%报10.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483629302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483629302?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:45","pubTimestamp":1731689154,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日00时45分,Cormedix Inc.股票出现波动,股价急速下跌5.00%。截至发稿,该股报10.45美元/股,成交量51.0931万股,换手率0.84%,振幅4.00%。Cormedix Inc.股票所在的生物技术行业中,整体跌幅为3.67%。Cormedix Inc.公司简介:Cormedix Inc 是一家生物制药公司,专注于开发和商业化用于预防和治疗传染病和炎症性疾病的治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116004554a23ba498&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116004554a23ba498&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRMD","BK4007"],"gpt_icon":0},{"id":"2482737535","title":"Cormedix Inc.盘中异动 大幅拉升5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482737535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482737535?lang=zh_cn&edition=full","pubTime":"2024-11-12 00:42","pubTimestamp":1731343321,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日00时42分,Cormedix Inc.股票出现波动,股价大幅拉升5.09%。Cormedix Inc.股票所在的生物技术行业中,整体涨幅为0.01%。其相关个股中,Cero Therapeutics Holdings, Inc.、Aligos Therapeutics, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大,Cero Therapeutics Holdings, Inc.、Revelation Biosciences, Inc.、Elevai Labs, Inc.较为活跃,换手率分别为651.37%、483.81%、194.73%,振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Aligos Therapeutics, Inc.、Lakeshore Biopharma Co., Ltd,振幅分别为123.43%、72.42%、61.39%。Cormedix Inc.公司简介:Cormedix Inc 是一家生物制药公司,专注于开发和商业化用于预防和治疗传染病和炎症性疾病的治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112004201971a5c45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112004201971a5c45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALGS","BK4007","BK4139","CRMD","BK4505"],"gpt_icon":0},{"id":"2482485927","title":"Cormedix Inc.2024财年第三财季实现净利润-2.78百万美元,同比增加71.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482485927","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482485927?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:00","pubTimestamp":1731081621,"startTime":"0","endTime":"0","summary":"11月9日,Cormedix Inc.公布财报,公告显示公司2024财年第三财季净利润为-2.78百万美元,同比增加71.46%;其中营业收入为11.46百万美元,每股基本收益为-0.05美元。从资产负债表来看,Cormedix Inc.总负债18.87百万美元,其中短期债务163449.00美元,资产负债比为4.12,流动比率为3.96。机构评级:截至2024年11月9日,当前有5家机构对Cormedix Inc.目标价做出预测,其中目标均价为17.00美元,其中最低目标价为11.00美元,最高目标价为20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000030abae6d8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000030abae6d8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRMD"],"gpt_icon":0},{"id":"2481100331","title":"Cormedix Inc.盘中异动 股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481100331","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481100331?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:16","pubTimestamp":1731078989,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日23时16分,Cormedix Inc.股票出现异动,股价快速上涨5.08%。Cormedix Inc.股票所在的生物技术行业中,整体涨幅为0.61%。其相关个股中,60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Psyence Biomedical Ltd C/Wts 25/01/2029、Fortrea Holdings Inc.涨幅较大,Elevai Labs, Inc.、Matinas Biopharma Holdings, Inc.、Lipella Pharmaceuticals Inc.较为活跃,换手率分别为553.92%、48.00%、42.05%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Celularity Inc C/Wts 16/07/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ,振幅分别为86.00%、40.00%、31.72%。Cormedix Inc.公司简介:Cormedix Inc 是一家生物制药公司,专注于开发和商业化用于预防和治疗传染病和炎症性疾病的治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110823162998e4182c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110823162998e4182c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CRMD"],"gpt_icon":0},{"id":"2481682142","title":"Cormedix Inc.盘中异动 早盘股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481682142","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481682142?lang=zh_cn&edition=full","pubTime":"2024-11-06 00:08","pubTimestamp":1730822932,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日00时08分,Cormedix Inc.股票出现异动,股价快速拉升5.11%。截至发稿,该股报10.08美元/股,成交量32.9811万股,换手率0.54%,振幅5.01%。Cormedix Inc.股票所在的生物技术行业中,整体涨幅为0.73%。Cormedix Inc.公司简介:Cormedix Inc 是一家生物制药公司,专注于开发和商业化用于预防和治疗传染病和炎症性疾病的治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106000852a218f4d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106000852a218f4d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRMD","BK4007"],"gpt_icon":0},{"id":"1138201089","title":"异动解读 | CorMedix Inc.股价大涨5.11% 分析师看好主打产品前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1138201089","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138201089?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:24","pubTimestamp":1730733874,"startTime":"0","endTime":"0","summary":"美国生物制药公司CorMedix Inc.(CRMD)周五盘中股价大涨5.11%,报收于10.50美元/股,引发市场关注。\n\n分析人士认为,该股价上涨或与机构对公司主打产品DefenCath的看好有关。该产品专门用于预防和治疗感染性疾病和炎症性疾病,已处于商业化的最后阶段。如果能顺利推向美国及其他主要市场,将为公司带来不菲收益。\n\n此外,公司最新财报显示营收同比有所增长,达到1146万美元。尽管净利润仍为负值,但亏损幅度有所收窄。在分析师看来,财报数据总体向好,增强了投资者对公司长期发展前景的信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CRMD"],"gpt_icon":0},{"id":"2480587365","title":"Cormedix Inc.盘中异动 快速上涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480587365","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480587365?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:09","pubTimestamp":1730732951,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日23时09分,Cormedix Inc.股票出现波动,股价快速拉升5.11%。截至发稿,该股报10.50美元/股,成交量25.4784万股,换手率0.42%,振幅5.81%。Cormedix Inc.股票所在的生物技术行业中,整体跌幅为0.03%。Cormedix Inc.公司简介:Cormedix Inc 是一家生物制药公司,专注于开发和商业化用于预防和治疗传染病和炎症性疾病的治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110423091198e404e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110423091198e404e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CRMD"],"gpt_icon":0},{"id":"1119636395","title":"异动解读 | CorMedix 财报数据不佳导致股价大跌近26%","url":"https://stock-news.laohu8.com/highlight/detail?id=1119636395","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119636395?lang=zh_cn&edition=full","pubTime":"2024-10-30 23:17","pubTimestamp":1730301463,"startTime":"0","endTime":"0","summary":"CorMedix Inc.是一家生物技术公司,专注于开发和商业化治疗和预防心血管疾病、代谢疾病、慢性肾病等领域的新型抗生素和其他治疗方案。该公司最新财报数据一经公布,股价随即出现近26%的大幅下跌。财报显示,CorMedix在截至2024年1月1日的季度中,调整后每股亏损5美分,高于去年同期的每股亏损17美分,也未达分析师平均预期的每股亏损10美分。分析人士指出,CorMedix此前经历了长期的业绩低迷和股价低迷,投资者原本对公司最新季度业绩有所期许。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CRMD"],"gpt_icon":0},{"id":"2479871327","title":"CorMedix Inc 报告截至 1 月 1 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2479871327","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479871327?lang=zh_cn&edition=full","pubTime":"2024-10-30 23:13","pubTimestamp":1730301193,"startTime":"0","endTime":"0","summary":" * CorMedix Inc 报告,截至1月1日的季度调整后每股亏损5美分,高于去年同期的每股-17美分。四位分析师对该季度的平均预期是每股亏损 10 美分。华尔街预期为每股-13美分至-6美分。* 营收为 1146 万美元,分析师预期为 1084 万美元。* CorMedix Inc公布的本季度每股收益为亏损5美分。* 该公司当季亏损 278 万美元。* CorMedix Inc的股价本季度上涨了60.5%,今年迄今为止上涨了244.9%。华尔街对 CorMedix 公司 12 个月目标价的中位数为 13.50 本摘要由 LSEG 10 月 30 日 03:12 p.m. UTC 调制解调器器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"CorMedix Inc 报告截至 1 月 1 日的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRMD","BK4007"],"gpt_icon":0},{"id":"2479259157","title":"Cormedix Inc.盘中异动 临近收盘快速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479259157","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479259157?lang=zh_cn&edition=full","pubTime":"2024-10-30 03:47","pubTimestamp":1730231229,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日03时47分,Cormedix Inc.股票出现波动,股价急速跳水5.00%。Cormedix Inc.股票所在的生物技术行业中,整体跌幅为0.31%。其相关个股中,Glycomimetics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Lixte Biotechnology Holdings, Inc.涨幅较大,Glycomimetics, Inc.、Lixte Biotechnology Holdings, Inc.、Novabay Pharmaceuticals, Inc.较为活跃,换手率分别为1691.86%、1434.57%、361.40%,振幅较大的相关个股有Glycomimetics, Inc.、Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Dermata Therapeutics Inc C/Wts ,振幅分别为183.65%、88.24%、78.31%。Cormedix Inc.公司简介:Cormedix Inc 是一家生物制药公司,专注于开发和商业化用于预防和治疗传染病和炎症性疾病的治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030034709a1f65d34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030034709a1f65d34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRMD","BK4007"],"gpt_icon":0},{"id":"2478488473","title":"CorMedix Inc 预计每股亏损 10 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2478488473","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478488473?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:02","pubTimestamp":1730120531,"startTime":"0","endTime":"0","summary":" * CorMedix Inc 将于10月30日公布截至2024年9月30日的财报,预计该公司的季度收入将有所增长。* LSEG分析师对CorMedix公司的平均预期是每股亏损10美分。* 目前,分析师对该公司股票的平均评级为 \"买入\",建议分类为 4 个 \"强烈买入 \"或 \"买入\",没有 \"持有\",也没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 CorMedix Inc 的 12 个月目标价中位数为 13.50 美元,高于其最后收盘价 13.04 美元。10月28日 - 本摘要于北京时间 10 月 28 日 13:01 机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"CorMedix Inc 预计每股亏损 10 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRMD"],"gpt_icon":0},{"id":"2478935780","title":"Cormedix Inc.盘中异动 急速拉升5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478935780","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478935780?lang=zh_cn&edition=full","pubTime":"2024-10-25 21:53","pubTimestamp":1729864437,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日21时53分,Cormedix Inc.股票出现波动,股价大幅上涨5.13%。Cormedix Inc.股票所在的生物技术行业中,整体涨幅为0.63%。其相关个股中,Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Elevai Labs, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,180 Life Sciences Corp.、Elevai Labs, Inc.、Tc Biopharm Plc较为活跃,换手率分别为658.43%、548.63%、91.60%,振幅较大的相关个股有Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Elevai Labs, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ,振幅分别为77.79%、62.91%、57.09%。Cormedix Inc.公司简介:Cormedix Inc 是一家生物制药公司,专注于开发和商业化用于预防和治疗传染病和炎症性疾病的治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025215357a1ea8ebe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025215357a1ea8ebe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4183","BK4007","CRMD","ELAB"],"gpt_icon":0},{"id":"2477552646","title":"Cormedix Inc.盘中异动 大幅下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477552646","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477552646?lang=zh_cn&edition=full","pubTime":"2024-10-24 23:09","pubTimestamp":1729782572,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日23时09分,Cormedix Inc.股票出现波动,股价大幅下跌5.01%。Cormedix Inc.股票所在的生物技术行业中,整体涨幅为0.10%。其相关个股中,Biovie Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Dbv Technologies涨幅较大,Qualigen Therapeutics, Inc.、Cns Pharmaceuticals, Inc.、Genprex, Inc.较为活跃,换手率分别为246.13%、169.63%、121.80%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Qualigen Therapeutics, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ,振幅分别为77.83%、71.78%、60.32%。Cormedix Inc.公司简介:Cormedix Inc 是一家生物制药公司,专注于开发和商业化用于预防和治疗传染病和炎症性疾病的治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024230932ab70d934&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024230932ab70d934&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRMD","BK4007"],"gpt_icon":0},{"id":"2477363449","title":"Cormedix Inc.盘中异动 下午盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477363449","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477363449?lang=zh_cn&edition=full","pubTime":"2024-10-23 01:09","pubTimestamp":1729616974,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日01时09分,Cormedix Inc.股票出现波动,股价大幅上涨5.01%。截至发稿,该股报11.76美元/股,成交量79.3103万股,换手率1.37%,振幅4.73%。Cormedix Inc.股票所在的生物技术行业中,整体跌幅为1.29%。Cormedix Inc.公司简介:Cormedix Inc 是一家生物制药公司,专注于开发和商业化用于预防和治疗传染病和炎症性疾病的治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023010934ab6c45d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023010934ab6c45d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CRMD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cormedix.com","stockEarnings":[{"period":"1week","weight":0.0227},{"period":"1month","weight":-0.202},{"period":"3month","weight":0.1612},{"period":"6month","weight":0.9522},{"period":"1year","weight":1.374},{"period":"ytd","weight":1.2793}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CorMedix Inc.是于2006年7月28日在美国特拉华州注册成立。该公司是一家生物制药公司,专注于开发和商业化治疗产品,用于预防和治疗危及生命的疾病和状况。该公司的主要重点是主导产品DefenCath的商业化。该公司已在全球范围内授权开发和商业化DefenCath。DefenCath这个名称是美国食品药品监督管理局(FDA)批准的美国专有名称。","yearOnYearQuotes":[{"month":1,"riseRate":0.642857,"avgChangeRate":0.156968},{"month":2,"riseRate":0.5,"avgChangeRate":0.081232},{"month":3,"riseRate":0.571429,"avgChangeRate":0.079611},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.050014},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.15479},{"month":6,"riseRate":0.533333,"avgChangeRate":0.055667},{"month":7,"riseRate":0.466667,"avgChangeRate":0.062594},{"month":8,"riseRate":0.533333,"avgChangeRate":0.009001},{"month":9,"riseRate":0.4,"avgChangeRate":0.043586},{"month":10,"riseRate":0.466667,"avgChangeRate":0.048734},{"month":11,"riseRate":0.466667,"avgChangeRate":0.057838},{"month":12,"riseRate":0.4,"avgChangeRate":0.052489}],"exchange":"NASDAQ","name":"CorMedix Inc.","nameEN":"CorMedix Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CorMedix Inc.(CRMD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CorMedix Inc.(CRMD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CorMedix Inc.,CRMD,CorMedix Inc.股票,CorMedix Inc.股票老虎,CorMedix Inc.股票老虎国际,CorMedix Inc.行情,CorMedix Inc.股票行情,CorMedix Inc.股价,CorMedix Inc.股市,CorMedix Inc.股票价格,CorMedix Inc.股票交易,CorMedix Inc.股票购买,CorMedix Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CorMedix Inc.(CRMD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CorMedix Inc.(CRMD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}